postpartum depression Tag

Skylark Postpartum Depression Study

To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This is a PHASE 3...